Back

Diuretic resistance and associated mortality outcomes among patients in the cardiac intensive care unit

21 March 2026 (09:40 - 10:25)
Organised by: Logo
Congress Presentation Part of: Improving the ICU care: from early monitoring to advanced management Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care ACVC Premium Access ESC Acute CardioVascular Care 2026 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Doctor Parth Patel

Mayo Clinic, Rochester (United States of America)

5 More presentations in this session

Presentation thumbnail
Arterial versus mixed venous lactate levels in 1579 cardiac intensive care patients
Professor C. Vandenbriele (London, GB)
Abstract
Presentation thumbnail
Single-dose high-sensitivity cardiac troponin for prognostic evaluation in syncope
Doctor C. Baldin (Porto Alegre, BR)
Abstract
Presentation thumbnail
Enhancing prehospital management of acute coronary syndrome: a continuous improvement approach
Mrs C. Toth (Sao Paulo, BR)
Abstract
Presentation thumbnail
Trends in the clinical profile, management and prognosis of type A aortic syndrome over the last 25 years
Doctor I. Arrieta Llorente (Barcelona, ES)
Abstract
Presentation thumbnail
Admission neutrophil-lymphocyte profile and adverse in-hospital outcomes in myocarditis: a nationwide cohort analysis
Doctor K. Kim (Incheon, KR)
Abstract

Access the full session

Session thumbnail
Improving the ICU care: from early monitoring to advanced management

The Event

Event poster

ESC Acute CardioVascular Care 2026

21 March 2026 09:40 CET
You may be interested in
thumbnail
Congress Presentation
Acute heart failure patients with diuretic resistance: who are they and prognostic implications of diuretic resistance. The experience of a general hospital
thumbnail
Congress Presentation
Early assessment of diuretic resistance: predictive factors and impact on outcomes of patients with acute heart failure.
thumbnail
Congress Presentation
Rescue ultrafiltration indication in acute heart failure hospitalizations: time trends in temporary use, predictors and clinical implications.

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources